Chartwell Investment Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Chartwell Investment Partners, LLC

$2.91 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$314.42 - $351.91 $326,367 - $365,282	1,038 Added 10.5%	10,927 $3.85 Million
Q4 2022 Feb 15, 2023	BUY	$285.76 - $321.48 $1.83 Million - $2.06 Million	6,399 Added 183.35%	9,889 $2.86 Million
Q2 2022 Aug 01, 2022	SELL	$234.96 - $292.55 $952,762 - $1.19 Million	-4,055 Reduced 53.74%	3,490 $983,000
Q1 2022 Apr 26, 2022	BUY	$221.42 - $260.97 $97,646 - $115,087	441 Added 6.21%	7,545 $1.97 Million
Q4 2021 Feb 15, 2022	BUY	$177.01 - $223.45 $301,448 - $380,535	1,703 Added 31.53%	7,104 $1.56 Million
Q2 2021 Jul 19, 2021	SELL	$187.49 - $221.1 $1.97 Million - $2.32 Million	-10,487 Reduced 66.01%	5,401 $1.09 Million
Q1 2021 May 03, 2021	SELL	$207.02 - $241.31 $321,502 - $374,754	-1,553 Reduced 8.9%	15,888 $3.42 Million
Q4 2020 Feb 09, 2021	SELL	$207.01 - $276.09 $937,962 - $1.25 Million	-4,531 Reduced 20.62%	17,441 $4.12 Million
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $426,168 - $505,267	1,667 Added 8.21%	21,972 $5.98 Million
Q2 2020 Jul 29, 2020	BUY	$225.48 - $295.8 $137,768 - $180,733	611 Added 3.1%	20,305 $5.9 Million
Q1 2020 Apr 30, 2020	SELL	$199.77 - $247.81 $48,943 - $60,713	-245 Reduced 1.23%	19,694 $4.69 Million
Q4 2019 Jan 29, 2020	SELL	$166.71 - $223.91 $4,001 - $5,373	-24 Reduced 0.12%	19,939 $4.37 Million
Q3 2019 Oct 29, 2019	SELL	$166.23 - $187.09 $61,671 - $69,410	-371 Reduced 1.82%	19,963 $3.38 Million
Q2 2019 Aug 19, 2019	SELL	$164.61 - $190.37 $360,166 - $416,529	-2,188 Reduced 9.71%	20,334 $3.73 Million
Q1 2019 Apr 11, 2019	SELL	$163.73 - $194.7 $617,098 - $733,824	-3,769 Reduced 14.34%	22,522 $4.14 Million
Q4 2018 Feb 01, 2019	BUY	$151.91 - $192.21 $408,485 - $516,852	2,689 Added 11.39%	26,291 $4.36 Million
Q3 2018 Nov 08, 2018	BUY	$167.73 - $192.74 $528,517 - $607,323	3,151 Added 15.41%	23,602 $4.55 Million
Q2 2018 Aug 09, 2018	BUY	$145.72 - $169.96 $2.01 Million - $2.35 Million	13,807 Added 207.81%	20,451 $3.48 Million
Q1 2018 May 08, 2018	SELL	$151.6 - $177.13 $6,367 - $7,439	-42 Reduced 0.63%	6,644 $996,000
Q1 2018 May 08, 2018	BUY	$151.6 - $177.13 $6,367 - $7,439	42 Added 0.63%	6,686 $1.09 Million
Q4 2017 Feb 08, 2018	SELL	$137.28 - $155.55 $606,503 - $687,219	-4,418 Reduced 39.94%	6,644 $996,000
Q3 2017 Nov 08, 2017	BUY	$148.13 - $162.24 $1.64 Million - $1.79 Million	11,062	11,062 $1.68 Million

Others Institutions Holding VRTX

# of Institutions

1,752

Shares Held

227M

Call Options Held

1.63M

Put Options Held

1.47M

Capital World Investors Los Angeles, CA

28.3M
Shares

$13.4 Billion
1.8% of portfolio
Vanguard Group Inc Valley Forge, PA

23.3M
Shares

$11 Billion
0.17% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.1 Billion
0.23% of portfolio
State Street Corp Boston, MA

12M
Shares

$5.65 Billion
0.2% of portfolio
Capital Research Global Investors Los Angeles, CA

10.4M
Shares

$4.92 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Account